{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:53:38Z","timestamp":1781567618670,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05918-2","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:47:58Z","timestamp":1777434478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of sacubitril\/valsartan and SGLT2 inhibitors on arrhythmia burden in ICD patients"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8865-0301","authenticated-orcid":false,"given":"Fatih","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-4303","authenticated-orcid":false,"given":"Mehmet","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"5918_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/circresaha.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646\u201359. https:\/\/doi.org\/10.1161\/circresaha.113.300268.","journal-title":"Circ Res"},{"key":"5918_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijcard.2019.03.063","volume":"286","author":"M Cameli","year":"2019","unstructured":"Cameli M, Sciaccaluga C, Loiacono F, Simova I, Miglioranza MH, Nistor D, Bandera F, Emdin M, Giannoni A, Ciccone MM, Devito F, Guaricci AI, Favale S, Lisi M, Mandoli GE, Henein M, Mondillo S. The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study. Int J Cardiol. 2019;286:87\u201391. https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.063.","journal-title":"Int J Cardiol"},{"key":"5918_CR3","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ehf2.14416","volume":"10","author":"VE Santobuono","year":"2023","unstructured":"Santobuono VE, Favale S, D\u2019Onofrio A, Manzo M, Cal\u00f2 L, Bertini M, Savarese G, Santini L, Dello Russo A, Lavalle C, Viscusi M, Amellone C, Calvanese R, Arena G, Pangallo A, Rapacciuolo A, Porcelli D, Campari M, Valsecchi S, Guaricci AI. Performance of a multisensor implantable defibrillator algorithm for heart failure monitoring related to co-morbidities. ESC Heart Fail. 2023;10:2469\u201378. https:\/\/doi.org\/10.1002\/ehf2.14416.","journal-title":"ESC Heart Fail"},{"key":"5918_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2021.10.008","volume":"345","author":"Z He","year":"2021","unstructured":"He Z, Yang L, Nie Y, Wang Y, Wang Y, Niu X, Bai M, Yao Y, Zhang Z. Effects of SGLT-2 inhibitors on health-related quality of life and exercise capacity in heart failure patients with reduced ejection fraction: A systematic review and meta-analysis. Int J Cardiol. 2021;345:83\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2021.10.008.","journal-title":"Int J Cardiol"},{"key":"5918_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ejhf.2419","volume":"24","author":"JP Curtain","year":"2022","unstructured":"Curtain JP, Jackson AM, Shen L, Jhund PS, Docherty KF, Petrie MC, Castagno D, Desai AS, Rohde LE, Lefkowitz MP, Rouleau JL, Zile MR, Solomon SD, Swedberg K, Packer M, McMurray JJV. Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF. Eur J Heart Fail. 2022;24:551\u201361. https:\/\/doi.org\/10.1002\/ejhf.2419.","journal-title":"Eur J Heart Fail"},{"key":"5918_CR6","doi-asserted-by":"publisher","unstructured":"Valentim Gon\u00e7alves A, Pereira-da-Silva T, Galrinho A, Rio P, Moura Branco L, Soares R, Feliciano J, Ilh\u00e3o Moreira R, Cruz Ferreira R. Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement? J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/jcm8060869.","DOI":"10.3390\/jcm8060869"},{"key":"5918_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-021-01293-8","volume":"20","author":"HL Li","year":"2021","unstructured":"Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021;20:100. https:\/\/doi.org\/10.1186\/s12933-021-01293-8.","journal-title":"Cardiovasc Diabetol"},{"key":"5918_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","volume":"108","author":"P Martens","year":"2019","unstructured":"Martens P, Nuyens D, Rivero-Ayerza M, Van Herendael H, Vercammen J, Ceyssens W, Luwel E, Dupont M, Mullens W. Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction. Clin Res Cardiol. 2019;108:1074\u201382. https:\/\/doi.org\/10.1007\/s00392-019-01440-y.","journal-title":"Clin Res Cardiol"},{"key":"5918_CR9","doi-asserted-by":"publisher","unstructured":"Sutanto H, Dobrev D, Heijman J. Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22168994.","DOI":"10.3390\/ijms22168994"},{"key":"5918_CR10","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:e263\u2013421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012.","journal-title":"J Am Coll Cardiol"},{"key":"5918_CR11","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42:4901. https:\/\/doi.org\/10.1093\/eurheartj\/ehab670.","journal-title":"Eur Heart J"},{"key":"5918_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","volume":"15","author":"C de Diego","year":"2018","unstructured":"de Diego C, Gonz\u00e1lez-Torres L, N\u00fa\u00f1ez JM, Centuri\u00f3n Inda R, Martin-Langerwerf DA, Sangio AD, Chochowski P, Casasnovas P, Blazqu\u00e9z JC, Almendral J. Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm. 2018;15:395\u2013402. https:\/\/doi.org\/10.1016\/j.hrthm.2017.11.012.","journal-title":"Heart Rhythm"},{"key":"5918_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","volume":"67","author":"GA Roth","year":"2016","unstructured":"Roth GA, Poole JE, Zaha R, Zhou W, Skinner J, Morden NE. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation. J Am Coll Cardiol. 2016;67:1062\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.046.","journal-title":"J Am Coll Cardiol"},{"key":"5918_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233\u201370. https:\/\/doi.org\/10.1093\/ehjci\/jev014.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"5918_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077.","journal-title":"N Engl J Med"},{"key":"5918_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1253\/circj.CJ-23-0349","volume":"88","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, Ohishi T, Iimori T, Kitamura T. Efficacy and Safety of Sacubitril\/Valsartan in Japanese Patients With Heart Failure According to Baseline Systolic Blood Pressure\u3000- Results From a Subgroup Analysis of the PARALLEL-HF Study. Circ J. 2023;88:53\u201361. https:\/\/doi.org\/10.1253\/circj.CJ-23-0349.","journal-title":"Circ J"},{"key":"5918_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2022.01.004","volume":"350","author":"E Carluccio","year":"2022","unstructured":"Carluccio E, Dini FL, Bitto R, Ciccarelli M, Correale M, D\u2019Agostino A, Dattilo G, Ferretti M, Grelli A, Guida S, Jacoangeli F, Lupi L, Luschi L, Masarone D, Mercurio V, Pacileo G, Pugliese NR, Rispoli A, Scelsi L, Tocchetti CG, Brunetti ND, Palazzuoli A, Piepoli M, Nodari S, Ambrosio G. Benefit from sacubitril\/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study. Int J Cardiol. 2022;350:62\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2022.01.004.","journal-title":"Int J Cardiol"},{"key":"5918_CR18","doi-asserted-by":"publisher","first-page":"e12435","DOI":"10.1111\/1755-5922.12435","volume":"36","author":"P Martens","year":"2018","unstructured":"Martens P, Beli\u00ebn H, Dupont M, Vandervoort P, Mullens W. The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction. Cardiovasc Ther. 2018;36:e12435. https:\/\/doi.org\/10.1111\/1755-5922.12435.","journal-title":"Cardiovasc Ther"},{"key":"5918_CR19","doi-asserted-by":"publisher","unstructured":"Romano G, Vitale G, Ajello L, Agnese V, Bellavia D, Caccamo G, Corrado E, Di Gesaro G, Falletta C, La Franca E, Min\u00e0 C, Storniolo SA, Sarullo FM, Clemenza F. The Effects of Sacubitril\/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The Hemodynamic Recovery. J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/jcm8122165.","DOI":"10.3390\/jcm8122165"},{"key":"5918_CR20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Duk\u00e1t A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sj\u00f6strand M, Langkilde AM. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303.","journal-title":"N Engl J Med"},{"key":"5918_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jjcc.2024.09.005","volume":"85","author":"P Basile","year":"2025","unstructured":"Basile P, Monitillo F, Santoro D, Falco G, Carella MC, Khan Y, Moretti A, Santobuono VE, Memeo R, Pontone G, Forleo C, Ciccone MM, Guaricci AI. Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring. J Cardiol. 2025;85:229\u201334. https:\/\/doi.org\/10.1016\/j.jjcc.2024.09.005.","journal-title":"J Cardiol"},{"key":"5918_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12933-024-02309-9","volume":"23","author":"S Fujiki","year":"2024","unstructured":"Fujiki S, Iijima K, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Shimizu W, Tomita H, Watanabe M, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Hayashi H, Maemura K, Niwano S, Umemoto T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Minamino T. Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial. Cardiovasc Diabetol. 2024;23:224. https:\/\/doi.org\/10.1186\/s12933-024-02309-9.","journal-title":"Cardiovasc Diabetol"},{"key":"5918_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12933-024-02137-x","volume":"23","author":"J Liao","year":"2024","unstructured":"Liao J, Ebrahimi R, Ling Z, Meyer C, Martinek M, Sommer P, Futyma P, Di Vece D, Schratter A, Acou WJ, Zhu L, Kiuchi MG, Liu S, Yin Y, P\u00fcrerfellner H, Templin C, Chen S. Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of >\u200980,000 patients (the SGLT2i-Arrhythmias and Sudden Cardiac Death). Cardiovasc Diabetol. 2024;23:78. https:\/\/doi.org\/10.1186\/s12933-024-02137-x.","journal-title":"Cardiovasc Diabetol"},{"key":"5918_CR24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/jce.16344","volume":"35","author":"MV Mariani","year":"2024","unstructured":"Mariani MV, Manzi G, Pierucci N, Laviola D, Piro A, D\u2019Amato A, Filomena D, Matteucci A, Severino P, Miraldi F, Vizza CD, Lavalle C. SGLT2i effect on atrial fibrillation: A network meta-analysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2024;35:1754\u201365. https:\/\/doi.org\/10.1111\/jce.16344.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"5918_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3390\/jcm15020719","volume":"15","author":"L Barone","year":"2026","unstructured":"Barone L, Sergi D, Maglia G, Bontempi L, Giaccardi M, Baroni M, Amellone C, Curnis A, D\u2019Alterio G, Saporito D, Vinciguerra P, Cipani S, Mazzone P, Giammaria M, Mitacchione G, Masarone D, Fabbri F, Vannelli A, Baldassarre I, Barill\u00e0 F. Impact of Sacubitril\/Valsartan on Cardiac Autonomic Function Assessed Using Physiological Data from Implantable Cardioverter-Defibrillators. J Clin Med. 2026;15(2):719. https:\/\/doi.org\/10.3390\/jcm15020719.","journal-title":"J Clin Med"},{"key":"5918_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jama.2019.12821","volume":"322","author":"JL Januzzi Jr","year":"2019","unstructured":"Januzzi JL Jr., Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Pi\u00f1a IL, Rocha RA, Shah AM, Williamson KM, Solomon SD. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. JAMA. 2019;322:1085\u201395. https:\/\/doi.org\/10.1001\/jama.2019.12821.","journal-title":"JAMA"},{"key":"5918_CR27","doi-asserted-by":"publisher","first-page":"e012272","DOI":"10.1161\/jaha.119.012272","volume":"8","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhou R, Lu C, Chen Q, Xu T, Li D. Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis. J Am Heart Assoc. 2019;8:e012272. https:\/\/doi.org\/10.1161\/jaha.119.012272.","journal-title":"J Am Heart Assoc"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05918-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:12:29Z","timestamp":1781565149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5918"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05918-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the Declaration of Helsinki, and Zonguldak B\u00fclent Ecevit University Ethics Committee approved the study (Approval Number: 2025\/17, Date: 01 October 2025). As the study involved retrospective review of existing medical records, the requirement for written informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"511"}}